The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Mechanisms of Action of Antimicrobials: Focus on Fluoroquinolones
Open accessAbstract
Five bacterial targets have been exploited in the development of antimicrobial drugs: cell wall synthesis, protein synthesis, ribonucleic acid synthesis, deoxyribonucleic acid (DNA) synthesis, and intermediary metabolism. Because resistance to drugs that interact with these targets is widespread, new antimicrobials and an understanding of their mechanisms of action are vital. The fluoroquinolones are the only direct inhibitors of DNA synthesis; by binding to the enzyme-DNA complex, they stabilize DNA strand breaks created by DNA gyrase and topoisomerase IV. Ternary complexes of drug, enzyme, and DNA block progress of the replication fork. Cytotoxicity of fluoroquinolones is likely a 2-step process involving (1) conversion of the topoisomerase-quinolone-DNA complex to an irreversible form and (2) generation of a double-strand break by denaturation of the topoisomerase. The molecular factors necessary for the transition from step 1 to step 2 remain unclear, but downstream pathways for cell death may overlap with those used by other bactericidal antimicrobials. Studies of fluoroquinolone-resistant mutants and purified topoisomerases indicate that many quinolones have differing activities against the two targets. Drugs with similar activities against both targets may prove less likely to select de novo resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
The complete genome sequence of the gastric pathogen Helicobacter pylori
Tomb, J.-F., White, O., Kerlavage, A. R., Clayton, R. A., Sutton, G. G., Fleischmann, R. D., Ketchum, K. A., Klenk, H. P., Gill, S., Dougherty, B. A., et al. (1997) · Nature · doi:10.1038/41483 · Cited by 3,529
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Drlica, K., & Zhao, X. (1997) · Microbiology and molecular biology reviews : MMBR · doi:10.1128/.61.3.377-392.1997 · Cited by 1,494
Complete Genome Sequence of Treponema pallidum, the Syphilis Spirochete
Fraser, C. M., Norris, S. J., Weinstock, G. M., White, O., Sutton, G. G., Dodson, R., Gwinn, M., Hickey, E. K., Clayton, R., Ketchum, K. A., et al. (1998) · Science · doi:10.1126/science.281.5375.375 · Cited by 1,081
Structure and mechanism of DNA topoisomerase II
Berger, J. M., Gamblin, S. J., Harrison, S. C., & Wang, J. C. (1996) · Nature · doi:10.1038/379225a0 · Cited by 859
Multimodular Penicillin-Binding Proteins: An Enigmatic Family of Orthologs and Paralogs
Goffin, C., & Ghuysen, J.-M. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.4.1079-1093.1998 · Cited by 636
Moyed, H. S., & Bertrand, K. P. (1983) · Journal of Bacteriology · doi:10.1128/jb.155.2.768-775.1983 · Cited by 625
New topoisomerase essential for chromosome segregation in E. coli
Kato, J.-I., Nishimura, Y., Imamura, R., Niki, H., Hiraga, S., & Suzuki, H. (1990) · Cell · doi:10.1016/0092-8674(90)90172-b · Cited by 566
Mechanisms of fluoroquinolone resistance
Hooper, D. C. (1999) · Drug Resistance Updates · doi:10.1054/drup.1998.0068 · Cited by 488
Self-citationCrystal structure of the breakage–reunion domain of DNA gyrase
Cabral, J. H. M., Jackson, A. P., Smith, C. V., Shikotra, N., Maxwell, A., & Liddington, R. C. (1997) · Nature · doi:10.1038/42294 · Cited by 456
Multiple Antibiotic Resistance in a Bacterium with Suppressed Autolytic System
TOMASZ, A., ALBINO, A., & ZANATI, E. (1970) · Nature · doi:10.1038/227138a0 · Cited by 429
Topoisomerase IV is a target of quinolones in Escherichia coli.
Khodursky, A. B., Zechiedrich, E. L., & Cozzarelli, N. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11801 · Cited by 378
Ferrero, L., Cameron, B., Manse, B., Lagneaux, D., Crouzet, J., Famechon, A., & Blanche, F. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00458.x · Cited by 378
Emergence of vancomycin tolerance in Streptococcus pneumoniae
Novak, R., Henriques, B., Charpentier, E., Normark, S., & Tuomanen, E. (1999) · Nature · doi:10.1038/21202 · Cited by 346
Vancomycin Derivatives That Inhibit Peptidoglycan Biosynthesis Without Binding d -Ala- d -Ala
Ge, M., Chen, Z., Russell, H., Onishi, Kohler, J., Silver, L. L., Kerns, R., Fukuzawa, S., Thompson, C., & Kahne, D. (1999) · Science · doi:10.1126/science.284.5413.507 · Cited by 318
Dong, Y., Zhao, X., Domagala, J., & Drlica, K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1756 · Cited by 278
Willmott, C. J., & Maxwell, A. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.1.126 · Cited by 252
Pan, X. S., & Fisher, L. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.2.471 · Cited by 237
Ng, E. Y., Trucksis, M., & Hooper, D. C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1881 · Cited by 232
Self-citationVancomycin Resistance: Structure of D-Alanine:D-Alanine Ligase at 2.3 Å Resolution
Fan, C., Moews, P. C., Walsh, C. T., & Knox, J. R. (1994) · Science · doi:10.1126/science.7939684 · Cited by 226
Quinolone-resistant mutations of the gyrA gene of Escherichia coli
Yoshida, H., Kojima, T., Yamagishi, J.-I., & Nakamura, S. (1988) · Molecular and General Genetics MGG · doi:10.1007/bf00338386 · Cited by 221
DNA Gyrase and Topoisomerase IV Are Dual Targets of Clinafloxacin Action in Streptococcus pneumoniae
Pan, X.-S., & Fisher, L. M. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.2810 · Cited by 215
Vancomycin-resistant enterococci
Murray, B. E. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80270-8 · Cited by 205
The Mechanism of Inhibition of Topoisomerase IV by Quinolone Antibacterials
Khodursky, A. B., & Cozzarelli, N. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27668 · Cited by 163
Hakenbeck, R., Grebe, T., Zähner, D., & Stock, J. B. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01521.x · Cited by 161
Quaternary changes in topoisomerase II may direct orthogonal movement of two DNA strands.
Berger, J. M., Fass, D., & Bogden, C. E. (1999) · Nature Structural Biology · doi:10.1038/7556 · Cited by 151
LytB, a novel pneumococcal murein hydrolase essential for cell separation
Garcı́a, P., González, M. P., Garcı́a, E., López, R., & García, J. L. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01238.x · Cited by 150
Willmott, C., Critchlow, S. E., Eperon, I. C., & Maxwell, A. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1586 · Cited by 136
Hiasa, H., Yousef, D. O., & Marians, K. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.42.26424 · Cited by 136
McCullers, J. A., English, B. K., & Novak, R. (2000) · The Journal of Infectious Diseases · doi:10.1086/315216 · Cited by 133
Inhibition of peptidoglycan biosynthesis by ramoplanin
Somner, E. A., & Reynolds, P. E. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.3.413 · Cited by 133
Mechanisms of Quinolone Resistance
Hooper, D. C. (2014) · ASM Press eBooks · doi:10.1128/9781555817817.ch3 · Cited by 129
Self-citationPan, X.-S., & Fisher, L. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1129 · Cited by 119
Fournier, B., Zhao, X., Lu, T., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2160-2165.2000 · Cited by 112
Scherrer, R., & Moyed, H. S. (1988) · Journal of Bacteriology · doi:10.1128/jb.170.8.3321-3326.1988 · Cited by 103
Insertional inactivation of the major autolysin gene of Streptococcus pneumoniae
Tomasz, A., Moreillon, P., & Pozzi, G. (1988) · Journal of Bacteriology · doi:10.1128/jb.170.12.5931-5934.1988 · Cited by 92
Lewin, C. S., Morrissey, I., & Smith, J. T. (1991) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01966996 · Cited by 92
Moreillon, P., Markiewicz, Z., Nachman, S., & Tomasz, A. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.1.33 · Cited by 90
DNA Cleavage Is Not Required for the Binding of Quinolone Drugs to the DNA Gyrase−DNA Complex
Critchlow, S. E., & Maxwell, A. (1996) · Biochemistry · doi:10.1021/bi9603175 · Cited by 89
Fournier, B., & Hooper, D. C. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.1.121 · Cited by 70
Self-citationBactrecidal mechanisms of ofloxacin
Lewin, S. C., & Smith, J. T. (1988) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/22.supplement_c.1 · Cited by 65
The lethal action of aminoglycoside
Davis, B. D. (1988) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/22.1.1 · Cited by 65
Silva, J. C., Haldimann, A., Prahalad, M. K., Walsh, C. T., & Wanner, B. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11951 · Cited by 62
Huang, W. M., Libbey, J. L., van der Hoeven, P., & Yu, S. X. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4652 · Cited by 44
Cited by
Lewis, K. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134306 · Cited by 1,858
Mechanism of Quinolone Action and Resistance
Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014) · Biochemistry · doi:10.1021/bi5000564 · Cited by 1,282
Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success
Redgrave, L. S., Sutton, S. B., Webber, M. A., & Piddock, L. J. V. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.04.007 · Cited by 1,008
Ciprofloxacin Causes Persister Formation by Inducing the TisB toxin in Escherichia coli
Dörr, T., Vulić, M., & Lewis, K. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000317 · Cited by 782
Killing by Bactericidal Antibiotics Does Not Depend on Reactive Oxygen Species
Keren, I., Wu, Y., Inocencio, J., Mulcahy, L. R., & Lewis, K. (2013) · Science · doi:10.1126/science.1232688 · Cited by 550
Metadata
- Authors
- Hooper, D. C.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-03-15
- Volume
- 32
- Issue
- Supplement_1
- Pages
- S9-S15
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2158728493
- Cited by
- 517
- References
- 44
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.